Concurrent Chemoradiotherapy Followed by PD-1 Inhibitor in Advanced Cervical Cancer

This study is testing whether adding a PD-1 inhibitor (an immunotherapy drug that helps the immune system attack cancer) after standard chemoradiation treatment improves outcomes for women with locally advanced cervical cancer. **You may be eligible if...** - You are between 18 and 75 years old - You have been diagnosed with locally advanced cervical cancer (not yet spread to distant organs) that has not been treated yet - You are in good enough health to receive radiation and chemotherapy together - Your blood, liver, and kidney function are within acceptable ranges **You may NOT be eligible if...** - Your cancer has already spread to distant parts of the body - You have an active autoimmune disease - You have had an organ transplant or have HIV - You are allergic to the immunotherapy drug being used - You have had another cancer within the past 5 years (except certain non-serious skin cancers) Talk to your doctor to see if this trial is right for you.